Comparison Between Ultra-low-dose Computed Tomography and Lung MRI in Cystic Fibrosis

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to compare the performances of ultra-low dose computed tomography (CT) and lung magnetic resonance imaging (MRI) for morphological assessment of cystic fibrosis-related lung disease and to compare their performances to conventional low dose CT

Detailed Description
-----------------
Cystic fibrosis (CF) is a recessive autosomal disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that encodes for an epithelial chloride channel involved in ion and fluid transport. CF is the most common inherited disease in Caucasians and disease severity mainly depends on the degree of lung involvement, which can lead to terminal respiratory failure Disease monitoring of CF-related lung disease rely on functional assessment and complimentary morphological assessment. Conventional low-dose chest computed tomography (CT) is currently the gold standard for the morphological assessment of CF-related lung disease but ultra-low dose chest CT and high-resolution magnetic resonance imaging (MRI) of the lung using UTE sequences have been recently developed and allow important radiation reduction of radiation dose exposure. However the performances of these 2 competing imaging methods remains to be compared.

Official Title
-----------------
Comparison Between Ultra-low-dose Computed Tomography and Lung MRI for Morphological Assessment of Lung Disease in Adult Cystic Fibrosis Patients

Conditions
-----------------
Cystic Fibrosis

Intervention / Treatment
-----------------
* Diagnostic Test: CT scanner
* Diagnostic Test: Lung MRI


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age ≥ 18 year-old Diagnosis of cystic fibrosis provided by genetic and swear test Chest CT acquisition performed as part of the standard follow-up Patient with social security or health insurance Informed consent Exclusion Criteria: MRI contraindication Orthopnea Inability to hold breath for 17 seconds No spirometry planned the same day Lung transplant patient

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Intervention/Treatment |
| --- |
|Diagnostic Test: CT scanner|1 conventional low dose inspiratory acquisition and 1 ultra-low-dose inspiratory acquisition|
|Diagnostic Test: Lung MRI|3 UTE sequences (free breathing, inspiratory and expiratory) and 1 T2 sequence|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Reproducibility of visual score between imaging modalities | Reproducibility disease severity measured by the Helbich scoring system with conventional CT as gold standard | 1 day | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Intra and interobserver reproducibility of visual scores | Intra and interobserver reproducibility of the Helbich score for each imaging modality | 1 day | 
| Correlation between visual scores and pulmonary function | Correlation between the Helbich score for each imaging modality and forced expiratory volume in 1 second (FEV1) | 1 day | 
| Correlation between air trapping at MRI and pulmonary function test | Correlation between air trapping, measured by comparing inspiratory to expiratory MRI images, and forced expiratory volume at one second (FEV1) | 1 day | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Magnetic resonance imaging, Multidetector computed tomography